Stephen Loper, PA
Surgical · American Fork, UTNPI 1164666061
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.7% of the total across 200 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 12.8% — the pattern of someone who eats at a lot of different presentations. Among surgical clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 200 payments — averaging $22.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$586
- Endo Pharmaceuticals Inc.$472
- AbbVie$410
- 180 Medical, Inc.$352
- Sumitomo Pharma America, Inc.$286
- Bayer$269
- plus $2K from 27 others
What the payments were for
- Food & beverage$4,28294%
- Education$2906%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 19 | $586 |
| Endo Pharmaceuticals Inc. | 22 | $472 |
| AbbVie(2 entities) | 23 | $410 |
| 180 Medical, Inc. | 15 | $352 |
| Sumitomo Pharma America, Inc. | 13 | $286 |
| Bayer | 11 | $269 |
| Ferring Pharmaceuticals Inc. | 9 | $226 |
| Endo USA, Inc. | 11 | $206 |
| Johnson & Johnson | 4 | $203 |
| Pfizer | 9 | $192 |
| Boston Scientific | 5 | $172 |
| Procept Biorobotics Corporation | 3 | $158 |
| Antares Pharma, Inc. | 7 | $109 |
| Coloplast | 4 | $93 |
| Travere Therapeutics, Inc. | 4 | $87 |
| Convatec Inc. | 6 | $85 |
| Dendreon Pharmaceuticals LLC | 4 | $70 |
| Laborie Medical Technologies Corp. | 2 | $68 |
| Teleflex LLC | 3 | $67 |
| Alnylam Pharmaceuticals Inc. | 3 | $60 |
| Myriad Genetic Laboratories, Inc. | 4 | $59 |
| Accord Healthcare, Inc. | 3 | $58 |
| Urovant Sciences Inc | 3 | $58 |
| Axonics, Inc. | 2 | $36 |
| Urogen Pharma, Inc. | 2 | $33 |
| Medtronic | 2 | $32 |
| Merck | 1 | $27 |
| Verity Pharmaceuticals Inc. | 1 | $20 |
| Civco Medical Instruments | 1 | $19 |
| Olympus America Inc. | 1 | $16 |
| Innovation Technologies Inc | 1 | $16 |
| Intuitive Surgical | 1 | $15 |
| Tolmar Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XIAFLEX$122
- ADSTILADRIN$122
- AquaBeam Robotic System$120
How this compares
$4,572 in reported general payments places this provider in the 95th percentile of 121 surgical providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 18 | $14,954 |
| Potassium Citrate ErPotassium Citrate | 17 | $3,860 |
| Methenamine Hippurate | 26 | $2,916 |
| Tamsulosin Hcl | 138 | $2,093 |
| Finasteride | 73 | $1,018 |
| Trospium Chloride | 14 | $922 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 23 | $565 |
| Solifenacin Succinate | 17 | $421 |
| Cephalexin | 46 | $400 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 56 | $398 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 15 | $342 |
| Oxybutynin Chloride | 16 | $123 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 13 | $59 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $586 | $14,95418 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 121 surgical providers in Utah.
Other surgical in American Fork
- Bradley BurtonAmerican Fork$3K
- Lindsay AdamsAmerican Fork$3K
- Jonathan BrownAmerican Fork$3K
- Scott HadfieldSalt Lake City$10K
- Brittany CrossSalt Lake City$6K
- Jason HoldenDraper$6K
- Drew LambourneProvo$4K
- Brittney TaylorSalt Lake City$4K
- Richard ClowardOgden$4K
- David TranterDraper$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.